Atlanta, GA, United States of America

Yiming Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Corporation of Mercer University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yiming Chen. Retrieved from https://idiyas.com/inventor/yiming-chen-1up4p0ji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yiming Chen: Innovator in Pharmaceutical Formulations

Introduction

Yiming Chen is a notable inventor based in Atlanta, GA, who has made significant contributions to the field of pharmaceutical formulations. With a focus on cathinone derivatives, his work has the potential to impact various therapeutic applications.

Latest Patents

Yiming Chen holds a patent for "Cathinone derivatives, pharmaceutical formulations, and methods." This patent includes compounds such as cathinone derivatives, which exhibit a first selectivity for a first receptor subtype that is at least 10 times greater than a second selectivity for a second receptor subtype from the same class of receptors. The methods described in the patent involve treating patients by administering a pharmaceutical formulation that includes these compounds.

Career Highlights

Yiming Chen is affiliated with Mercer University, where he contributes to research and development in the pharmaceutical sciences. His innovative work in the field has garnered attention and recognition, particularly for its potential applications in medicine.

Collaborations

Yiming Chen has collaborated with notable colleagues, including Clinton E Canal and Nader Moniri, to advance research in his area of expertise.

Conclusion

Yiming Chen's contributions to pharmaceutical formulations and his innovative approach to cathinone derivatives highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…